False Treatment Claims Still A COVID-19 Symptom: FTC Files Complaint Against California Firm

 
• By Malcolm Spicer
  
FTC alleges Precision Patient Outcomes changed the name of its product from COVID Resist to VIRUS Resist after the agency questioned advertising claiming it’s treatment for COVID-19. • Source: Federal Trade Commission

More from Archive

More from HBW Insight